2bnq: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2bnq.png|left|200px]] | [[Image:2bnq.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[2bnq]] is a 5 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNQ OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:15837811</ref><references group="xtra"/> | <ref group="xtra">PMID:15837811</ref><ref group="xtra">PMID:10878370</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Bossi, G.]] | [[Category: Bossi, G.]] | ||
| Line 47: | Line 46: | ||
[[Category: Flu]] | [[Category: Flu]] | ||
[[Category: Glycoprotein]] | [[Category: Glycoprotein]] | ||
[[Category: Immune system/receptor]] | |||
[[Category: Immune system/receptor/complex]] | |||
[[Category: Immunodominance]] | [[Category: Immunodominance]] | ||
[[Category: Mhc]] | [[Category: Mhc]] | ||
| Line 57: | Line 58: | ||
[[Category: Tcr]] | [[Category: Tcr]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
Revision as of 00:42, 15 March 2011
STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINESSTRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
Template:ABSTRACT PUBMED 15837811
About this StructureAbout this Structure
2bnq is a 5 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med. 2005 Apr 18;201(8):1243-55. PMID:15837811 doi:10.1084/jem.20042323
- ↑ Chen JL, Dunbar PR, Gileadi U, Jager E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol. 2000 Jul 15;165(2):948-55. PMID:10878370
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Bossi, G.
- Boultier, J M.
- Cerundolo, V.
- Chen, J L.
- Choi, E M.L.
- Dunbar, P R.
- Esnouf, R M.
- Griffiths, G.
- Held, G.
- Jackobsen, B K.
- Jones, E Y.
- Lissin, N M.
- Merwe, P A.Van Der.
- Renner, C.
- Rizkallah, P.
- Sami, M.
- Sewell, A.
- Stewart-Jones, G.
- Wooldridge, L.
- Complex
- Flu
- Glycoprotein
- Immune system/receptor
- Immune system/receptor/complex
- Immunodominance
- Mhc
- Peptide
- Polymorphism
- Receptor
- Signal
- Superagonist peptide t-cell vaccine
- T-cell
- Tcr
- Transmembrane